NCT06054971View on ClinicalTrials.gov

NSAA NON-Interventional Study Protocol

CompletedOBSERVATIONAL

Enrollment

31

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

February 3, 2025

Study Completion Date

March 13, 2025

Conditions

Duchenne Muscular Dystrophy

Interventions

OTHER

Remote Administration of NSAA

Remote Administration of NSAA

Trial Locations (1)

19355

Red Nucleus Solutions, Malvern

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Red Nucleus Enterprise Solutions, LLC

INDUSTRY